Overview


Structural biology is a field of molecular biology that focuses on the study of the three-dimensional structures of biological molecules. These molecules include proteins, nucleic acids (like DNA and RNA), and complex assemblies of macromolecules. Understanding the structures of these biological molecules is crucial for gaining insights into their functions and interactions. Proteins are essential biomolecules that perform various functions in living organisms. Enzymes, a type of protein, catalyze biochemical reactions. Understanding the structure of a protein can provide insights into its function. Also, DNA and RNA are nucleic acids that store and transfer genetic information. Knowing the three-dimensional structure of DNA and RNA helps scientists understand processes like replication, transcription, and translation. Many biological processes involve multiple molecules working together. Knowing how these macromolecules interact and fit together is crucial for understanding these processes.

Structural biology plays a crucial role in both drug development and drug discovery processes. In drug development, structural biology provides critical insights into the interactions between potential drug compounds and their target proteins. By elucidating the precise binding sites and conformations of these molecules, scientists can design more effective drugs with improved specificity and potency. Furthermore, structural biology is a powerful tool for identifying novel drug targets in the realm of drug discovery. By visualizing the three-dimensional structures of biological molecules, researchers can pinpoint vulnerabilities or functional sites within these targets.

FutureWise Market Research has published a report that provides an insightful analysis structural biology market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts’ structural biology market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • BiosolveIT GmbH
  • Thermo Fisher Scientific Inc.
  • Dassault Systemes
  • Optibrium Ltd.
  • Schrodinger
  • OpenEye Scientific Software, Inc.
  • Chemical Computing Group
  • Certara, L.P.
  • Cresset BioMolecular Discovery Ltd.
  • Acellera Ltd.
  • CGV S.A.
  • Simulations Plus, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The rising incidences of chronic disorders are expected to drive the market's growth over the forecast period. This imperative arises from the complex nature of these conditions, where insights into the three-dimensional structures of biological molecules become crucial. Structural biology techniques, like X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy, play a pivotal role in unraveling the complexities of molecular interactions, aiding researchers in the development of targeted therapies and precision medicine approaches. This rise in demand for molecular-level insights drives substantial growth in the structural biology market as it becomes increasingly necessary for more effective treatments for a spectrum of chronic illnesses. Moreover, advances in technologies such as cryo-electron microscopy, NMR spectroscopy, and X-ray crystallography have revolutionized the landscape of structural biology. These techniques allow scientists to study the intricate three-dimensional architectures of biomolecules with remarkable precision and detail. This upgraded capability has become essential to the pharmaceutical and biotechnology sectors, forming the foundation of drug discovery and development efforts. By providing crucial insights into the molecular underpinnings of diseases and potential therapeutic targets, structural biology empowers these industries to create more effective and tailored interventions, propelling the demand for associated technologies and services to unprecedented heights. However, the field of structural biology faces significant constraints, primarily embedded in financial and technical challenges. The acquisition and maintenance of specialized equipment and technologies demand substantial financial resources, potentially presenting a significant hurdle for smaller research entities or companies with limited budgets. Moreover, certain advanced techniques, such as cryo-electron microscopy, necessitate expertise and specialized training. This technical complexity acts as an additional barrier, impeding the accessibility of these powerful tools and techniques, particularly for institutions or individuals without the necessary resources or training infrastructure.

By Tools

  • SaaS and Standalone Modeling
  • Visualization and Analysis
  • Others

By Application

  • Drug Development
  • Drug Discovery
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing factors such as the rising prevalence of chronic disease, increasing geriatric population, well-established healthcare infrastructure, and increasing research and development activities are projected to fuel the growth of the structural biology market in the region. For example, as per the International Diabetes Federation, 537 million individuals aged between 20–79 years old have diabetes in 2021. In addition, technological advancements, drug discovery and development, the rise of structural genomics, growing government, and private funding, and increasing collaboration and partnership in the region are further driving the growth of the market over the projection period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Structural Biology Market By Tools, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Structural Biology Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Structural Biology Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Structural Biology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   Structural Biology Market, By Tools Historical Analysis and Forecast 2024-2032 (USD Million)
      1. SaaS and Standalone Modeling
      2. Visualization and Analysis
      3. Others
  • 8.  Structural Biology Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Drug Development
      2. Drug Discovery
      3. Others
  • 9.  North America Structural Biology Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 10.  Latin America Structural Biology Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 11.  Europe Structural Biology Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 12.  Asia Pacific Structural Biology Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032  

  • 13.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 14.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 15.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. BiosolveIT GmbH
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Thermo Fisher Scientific Inc.
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Dassault Systemes
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Optibrium Ltd.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Schrodinger
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. OpenEye Scientific Software, Inc.
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Chemical Computing Group
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Certara, L.P.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Cresset BioMolecular Discovery Ltd.
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Acellera Ltd.
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. CGV S.A.
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Simulations Plus, Inc.
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview

  • 16.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.  FutureWise SME Key Takeaway Points for Client
    •    

Partner

Our Clients